India  /  Published 18.11.20

India's hopes hinge on vaccines on trial at home

By G.S. Mudur in New Delhi

Business  /  Published 05.03.20

Nod for Zydus liver drug

Zydus Cadila on Thursday said it has received approval from the Drug Controller General of India (DCGI) for its new drug application for Saroglitazar to treat a particular condition of liver, known as...
By Vivek Nair in Ahmedabad

Business  /  Published 24.10.18

Zydus and parent Cadila bag Complan

Zydus Wellness and its parent Cadila Healthcare will jointly buy Heinz India in a deal worth Rs 4,595 crore.The two companies have signed definitive agreements to buy Heinz India, a subsidiary of Kraf...
By Our Special Correspondent in Mumbai

Business  /  Published 24.10.18

Heinz India to be sold for Rs 4,595cr

Cadila Healthcare along with Zydus Wellness will acquire Heinz India in a deal worth Rs 4,595 crore, a regulatory filing by the company said on Wednesday. The two companies have signed definitive agr...
By PTI in New Delhi


Download our latest App

to get update on the go...


Copyright © 2020 The Telegraph. All rights reserved.